Supporting and adequately funding the development of multipurpose prevention technologies (MPTs) should be a higher priority for the U.S. government, especially at a time when private sector support is missing. Unfortunately, current funding—while critical in advancing this important work to date—has not been sufficient. This inadequate funding may significantly hamper the timely development of MPTs that could be a huge boost to achieving U.S. global health priorities